Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice

Atherosclerosis

Volumn 168, Issue 2, 2003, Pages 255-262

  Zhou, Ji ^a,d   Møller, Jan ^a   Ritskes Hoitinga, Merel ^b   Larsen, Mogen L ^a   Austin, Richard C ^c   Falk, Erling ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c MCMASTER UNIVERSITY   (Canada)

^d HENDERSON RESEARCH CENTRE   (Canada)

Author keywords

apoE deficient mice; Atherosclerosis; Hyperhomocysteinemia

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; HOMOCYSTINE; METHIONINE; PYRIDOXINE; VITAMIN B GROUP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; AORTA ATHEROSCLEROSIS; AORTA ROOT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BRACHIOCEPHALIC TRUNK; CONTROLLED STUDY; DIET; FEMALE; HYPERHOMOCYSTEINEMIA; KNOCKOUT MOUSE; LIPID BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 0037497965     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00138-2     Document Type: Article

References (33)

1. Eikelboom J.W., Lonn E., Genest J. Jr., Hankey G., Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann. Intern. Med. 131:1999;363-375.
2. Zhou J., Moller J., Danielsen C.C., Bentzon J., Ravn H.B., Austin R.C., et al. Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21:2001;1470-1476.
3. Hofmann M.A., Lalla E., Lu Y., Gleason M.R., Wolf B.M., Tanji N., et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J. Clin. Invest. 107:2001;675-683.
4. Lentz S.R. Does homocysteine promote atherosclerosis? Arterioscler. Thromb. Vasc. Biol. 21:2001;1385-1386.
5. Selhub J., Jacques P.F., Wilson P.W., Rush D., Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J. Am. Med. Assoc. 270:1993;2693-2698.
6. Robinson K., Arheart K., Refsum H., Brattstrom L., Boers G., Ueland P., et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation. 97:1998;437-443.
7. Graham I.M., Daly L.E., Refsum H.M., Robinson K., Brattstrom L.E., Ueland P.M., et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. J. Am. Med. Assoc. 277:1997;1775-1781.
8. Verhoef P., Meleady R., Daly L.E., Graham I.M., Robinson K., Boers G.H. Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group. Eur. Heart. J. 20:1999;1234-1244.
9. Ubbink J.B., Vermaak W.J., van der Merwe A., Becker P.J., Delport R., Potgieter H.C. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J. Nutr. 124:1994;1927-1933.
10. Rimm E.B., Willett W.C., Hu F.B., Sampson L., Colditz G.A., Manson J.E., et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. J. Am. Med. Assoc. 279:1998;359-364.
11. Yap S., Naughten E.R., Wilcken B., Wilcken D.E., Boers G.H. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy. Semin. Thromb. Hemost. 26:2000;335-340.
12. Bellamy M.F., McDowell I.F., Ramsey M.W., Brownlee M., Newcombe R.G., Lewis M.J. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. Eur. J. Clin. Invest. 29:1999;659-662.
13. Verhaar M.C., Wever R.M., Kastelein J.J., van Loon D., Milstien S., Koomans H.A., et al. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial. Circulation. 100:1999;335-338.
14. Verhaar M.C., Rabelink T.J. Future for folates in cardiovascular disease. Eur. J. Clin. Invest. 29:1999;657-658.
15. Graham I.M., O'Callaghan P. The role of folic acid in the prevention of cardiovascular disease. Curr. Opin. Lipidol. 11:2000;577-587.
16. Reeves P.G., Nielsen F.H., Fahey G.C. Jr. AIN93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc writing committee on the reformulation of the AIN76-A rodent diet. J. Nutr. 123:1993;1935-1951.
17. Møller J., Rasmussen K. Homocysteine in plasma: stabilization of blood samples with fluoride. Clin. Chem. 41:1995;758-759.
18. Paigen B., Morrow A., Holmes P.A., Mitchell D., Williams R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68:1987;231-240.
19. -/- mice. J. Clin. Invest. 100:1997;1575-1580.
20. Bentzon J.F., Skovenborg E., Hansen C., Moller J., de Gaulejac N.S., Proch J., et al. Red wine does not reduce mature atherosclerosis in apolipoprotein E-deficient mice. Circulation. 103:2001;1681-1687.
21. Nutrient requirements of laboratory animals. 4th revised ed. 1995;National Academy Press, Washington, DC.
22. Lentz S.R., Erger R.A., Dayal S., Maeda N., Malinow M.R., Heistad D.D., et al. Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 279:2000;H970-H975.
23. Werstuck G.H., Lentz S.R., Dayal S., Hossain G.S., Sood S.K., Shi Y.Y., et al. Homocysteine-induced endiplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest. 107:2001;1263-1273.
24. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77:1986;1370-1376.
25. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J. Clin. Invest. 98:1996;5-7.
26. Eberhardt R.T., Forgione M.A., Cap A., Leopold J.A., Rudd M.A., Trolliet M., et al. Endothelial cell dysfunction in a murine model of mild hyperhomocyst(e)inemia. J. Clin. Invest. 106:2000;483-491.
27. Jacobsen D.W. Hyperhomocysteinemia and oxidative stress: time for a reality check? Arterioscler. Thromb. Vasc. Biol. 20:2000;1182-1184.
28. Verhaar M.C., Wever R.M., Kastelein J.J., van Dam T., Koomans H.A., Rabelink T.J. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation. 97:1998;237-241.
29. Verhaar M.C., Stroes E., Rabelink T.J. Folates and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 22:2002;6-13.
30. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14:1994;133-140.
31. Reddick R.L., Zhang S.H., Maeda N. Atherosclerosis in mice lacking apoE. Evaluation of lesional development and progression. Arterioscler. Thromb. 14:1994;141-147.
32. Falk E., Fuster V. Atherogenesis and its determinants. Fuster V., Alexander R.W., O'Rourke R.A., Roberts R., King S.B., Wellens H.J.J. Hurst's the heart. 10th ed. 2001;McGraw-Hill, New York. chapter 35.
33. Palinski W., Napoli C., Reaven P.D. Mouse models of atherosclerosis. Simon D.I., Rogers C. Vascular disease and injury: preclinical research. 2001;Humana Press, Totowa. chapter 12.